Fair Value Calculator Fair Value Calculator
EN DE

Swasti Vinayaka Synthetics Limited (SWASTIVI) Fair Value & Analysis

Consumer Cyclical · IN · Market cap ₹333M

SV Swasti Vinayaka Synthetics Limited SWASTIVI · BSE
Price₹3.70
Fair Value₹3.67
Upside-0.8%
Quality51/100
Watch Swasti Vinayaka Synthetics Limited for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹2.57 – ₹6.28

Fair value as of: Jul 6, 2026

From 26 valuation models · updated today

Share price −7.0% over the past month.

Price vs Fair Value (12 months)

₹6.09 ₹3.09 Fair Value ₹3.67 Jul 2025 Jul 2026

12‑month range ₹3.09 – ₹6.09 · fair‑value band ₹2.57 – ₹6.28 · the ₹3.70 price screens above the ₹3.67 fair value. As of Jul 6, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Swasti Vinayaka Synthetics Limited (SWASTIVI) currently trades at ₹3.70, while our model-based Fair Value estimate is ₹3.67 — implying the stock looks roughly 0.8% overvalued today. We read business quality at 51/100 (solid quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, Swasti Vinayaka Synthetics Limited generated revenue of ₹320M at a net margin of 9.5%. Revenue declined 35.1% year over year. It earns a return on equity of 12.4%. Net debt stands at ₹40.7M. Fundamentals as of Jul 6, 2026

Our scenario range runs from ₹2.57 (bear case) to ₹6.28 (bull case); at ₹3.70, the current price sits within that range. The share trades about 43% below its 52-week high and 23% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Cyclical peers we cover trades at 0% fair-value upside — at -1%, SWASTIVI screens richer than that median.

Key figures & financial health

Revenue (TTM) ₹320M
Revenue growth (YoY) -35.1%
Net margin 9.5%
Return on equity 12.4%
Free cash flow ₹7.9M FY2026
P/E ratio 11.2
More key figures
Operating margin 33.3%
EPS (TTM) ₹0.3300
EPS growth (YoY) +160%
Net debt ₹40.7M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 6, 2026. TTM = trailing twelve months.

About the company

Swasti Vinayaka Synthetics Limited manufactures and sells suiting, shirting, and other apparel products in India. It offers a range of shirting fabrics, including cotton, linen, lycra, polyester, viscose, and their blends. The company provides its uniform fabrics to corporate and government institutions. It also designs bridal and formal ethnic wear under the Ivy League brand; and supplies salwar kameez and tunics. The company markets its products through a network of agents/dealers, as well as directly to retail chains, the RMG sector, garment exporters, clothing brands, and corporate houses. The company was formerly known as Rajesh Synthetics Ltd. and changed its name to Swasti Vinayaka Synthetics Limited in September 1999. Swasti Vinayaka Synthetics Limited was incorporated in 1981 and is based in Mumbai, India.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

Swasti Vinayaka Synthetics Limited reported revenue of ₹320M in FY2026 versus ₹204M in FY2022, a compound +12.0%/yr. Reported net income was ₹30.5M in FY2026, compounding +15.0%/yr from FY2022.

Revenue +12.0%/yr
FY22 ₹204M
FY23 ₹268M
FY24 ₹307M
FY25 ₹384M
FY26 ₹320M
Net income +15.0%/yr
FY22 ₹17.5M
FY23 ₹19.9M
FY24 ₹19.8M
FY25 ₹24.2M
FY26 ₹30.5M

Is SWASTIVI fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "Swasti Vinayaka Synthetics Limited Fair Value". https://www.fairvalue-calculator.com/stock/SWASTIVI

Similar stocks

10 more Apparel Manufacturing stocks, each showing price versus our Fair Value estimate (as of Jul 6, 2026).

Stock Price Fair Value vs Fair Value
H & M Hennes & Mauritz AB HMB kr 166.80 kr 165.47 -1%
Ralph Lauren Corporation RL $366.55 $365.78 -0%
Moncler S.p.A MONC €50.90 €50.69 -0%
Gildan Activewear Inc GIL $57.04 $34.84 -39%
LPP SA LPP 18,350 PLN 20,063 PLN +9%
Levi Strauss & Co LEVI $23.61 $16.83 -29%
V.F. Corporation VFC $16.41 $9.93 -39%
Bosideng International Holdings 3998 HK$4.44 HK$5.92 +33%
Youngor Fashion Co 600177 ¥7.51 ¥7.87 +5%
Page Industries Limited PAGEIND ₹38,345 ₹9,665 -75%

Explore undervalued stocks

More undervalued Consumer Cyclical stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is Swasti Vinayaka Synthetics Limited (SWASTIVI) undervalued?
As of Jul 6, 2026, our model estimates a fair value of ₹3.67 versus a price of ₹3.70 — about −1% (overvalued). Model-based estimate, not financial advice.
What is the fair value of SWASTIVI?
Our model-based fair value for Swasti Vinayaka Synthetics Limited is ₹3.67 (as of Jul 6, 2026), built from audited fundamentals. The current price is ₹3.70.
What is the quality score of SWASTIVI?
Swasti Vinayaka Synthetics Limited has a Quality Score of 51/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of Swasti Vinayaka Synthetics Limited (SWASTIVI)?
Swasti Vinayaka Synthetics Limited reported trailing-twelve-month revenue of about ₹320M (latest available figure, as of Jul 6, 2026).
What is the net profit margin of SWASTIVI?
The net profit margin of Swasti Vinayaka Synthetics Limited is about 9.5%, meaning it keeps roughly 9.5% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.